Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach
Bin Hu,Jingchun Pei,Cheng Wan,Shuangshuang Liu,Zhe Xu,Yongwei Zou,Zhigao Li,Zhiwei Tang
DOI: https://doi.org/10.2147/jir.s461427
IF: 4.5
2024-07-13
Journal of Inflammation Research
Abstract:Bin Hu, 1 Jingchun Pei, 1 Cheng Wan, 1, 2 Shuangshuang Liu, 1 Zhe Xu, 3, 4 Yongwei Zou, 1 Zhigao Li, 1 Zhiwei Tang 1 1 Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China; 2 Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, People's Republic of China; 3 Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Kunming Medical University, Kunming, People's Republic of China; 4 School of Basic Medical Sciences, Qujing Medical College, Qujing, People's Republic of China Correspondence: Zhiwei Tang, Department of Neurosurgery, The First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, 650032, People's Republic of China, Email Ischemic stroke constitutes a significant global health care challenge, and a comprehensive understanding of its recovery mechanisms is imperative for the development of innovative therapeutic strategies. Angiogenesis, a pivotal element of ischemic tissue repair, facilitates the restoration of blood flow to damaged regions, thereby promoting neuronal regeneration and functional recovery. Nevertheless, the mechanisms underlying postischemic stroke angiogenesis remain incompletely elucidated. This review meticulously examines the constituents of the neurovascular unit, ion channels, molecular mediators, and signaling pathways implicated in angiogenesis following stroke. Furthermore, it delves into prospective therapeutic strategies informed by these factors. Our objective is to provide detailed and exhaustive information on the intricate mechanisms governing postischemic stroke angiogenesis, thus providing a robust scientific foundation for the advancement of novel neurorepair therapies. Keywords: ischemic stroke, angiogenesis, signaling pathways Stroke ranks as the second primary cause of mortality worldwide. 1 Between 1990 and 2019, the incidence of stroke increased by 85.0%, while mortality increased by 43.0%. 2 Particularly in China, the burden of stroke is notably severe and represents a major threat to the health and lives of its citizens. According to data from 2020, the overall prevalence of stroke in China was 2.6%, with an estimated 17.8 million adults having experienced a cerebrovascular event. 3,4 As the population ages, the incidence of stroke is projected to increase by 55.58%, the prevalence by 119.16%, and the mortality by 72.15% by 2030 compared to 2019 levels. 5 Although the mortality rate of ischemic stroke has decreased in recent decades, 6 more than half of survivors experience lasting disabilities, resulting in significant societal and economic burdens. 7 Ischemic strokes are predominantly caused by thrombosis or embolism, which disrupts cerebral blood flow and leads to regions of hypoxia and glucose deprivation, referred to as the ischemic penumbra. In the absence of prompt reperfusion, neuronal cells within the penumbra undergo apoptosis, which contributes to the formation of the ischemic core. 8 The onset of acute ischemic stroke rapidly inflicts substantial damage to cerebral tissue and neurons. 9 Contemporary therapeutic strategies for acute ischemic stroke include intravenous thrombolysis, endovascular thrombectomy, and neuroprotective agents. 10 Recombinant tissue plasminogen activator (rt-PA) remains the sole FDA-approved treatment for acute ischemic stroke, providing an approach for the dissolution of cerebral blood clots and reestablishment of cerebral perfusion, yielding prompt therapeutic outcomes. 11 Despite its effectiveness, the overall success rate for early thrombolytic intervention is disappointingly low. This low success rate is attributed to delays in administering treatment during the critical initial phase of stroke and the associated heightened risk of cerebral hemorrhage. 12 Furthermore, strokes caused by occlusions in major intracranial vessels, such as the internal carotid, middle cerebral, and basilar arteries, are particularly recalcitrant to intravenous rt-PA treatment and have an unfavorable prognosis. 13 Although endovascular thrombectomy improves recanalization rates in patients with ischemic stroke due to large artery occlusions, it has limited efficacy in cases of small vessel blockages. Moreover, surgical intervention can only be applied to specific patients. 14 Neurological recovery depends on angiogenesis and neural plasticity. The development of new blood vessels is regulated by the coordinated actions of multiple angiogenic factors rather than a single factor. Although the last two -Abstract Truncated-
immunology